Page last updated: 2024-11-02

pentobarbital and Blindness

pentobarbital has been researched along with Blindness in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollwich, F1
Dieckhues, B1
Overton, DA1

Other Studies

2 other studies available for pentobarbital and Blindness

ArticleYear
[Ocular light perception and metabolic activity of the liver (author's transl)].
    Klinische Monatsblatter fur Augenheilkunde, 1974, Volume: 164, Issue:4

    Topics: Animals; Bilirubin; Blindness; Cataract; Cataract Extraction; Chemical and Drug Induced Liver Injury

1974
Visual cues and shock sensitivity in the control of T-maze choice by drug conditions.
    Journal of comparative and physiological psychology, 1968, Volume: 66, Issue:1

    Topics: Animals; Blindness; Cues; Discrimination Learning; Electroshock; Male; Pentobarbital; Rats; Visual P

1968